Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.965
Delayed Data
As of 3:59pm ET
 +0.0305 / +3.26%
Today’s Change
0.64
Today|||52-Week Range
7.32
-33.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$446.4M

Company Description

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. MannKind was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Valencia, CA.

Contact Information

MannKind Corp.
28903 North Avenue Paine
Valencia California 91355
P:(661) 775-5300
Investor Relations:
(661) 295-4784

Employees

Shareholders

Individual stakeholders35.92%
Other institutional11.54%
Mutual fund holders10.42%

Top Executives

Matthew J. PfefferCEO, CFO, Director, VP & Head-Investor Relations
Raymond W. UrbanskiChief Medical Officer
Joseph KocinskyChief Technology Officer
David B. ThomsonSecretary, Vice President & General Counsel
Michael E. CastagnaChief Commercial Officer